NMT Medical, Inc. (NMTI)
OTOTC · Common · CUSIP 629294109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NMTI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
629294109
Market Cap
Micro Cap · $48 Million
Previous Name
Nitinol Medical Technologies, Inc.
Business: NMT Medical designs, develops and markets proprietary implant technologies that allow interventional cardiologists to treat cardiac sources of stroke and other potential brain attacks through minimally invasive, catheter-based procedures. NMT Medical is investigating the potential connection between a common cardiac defect called a patent foramen ovale (PFO) and brain attacks such as stroke, transient ischemic attacks (TIA's) and migraine headaches. A PFO can allow venous blood, unfiltered by the lungs, to enter the arterial circulation of the brain possibly triggering a cerebral event or brain attack. NMT is a leader in designing and developing implants to seal the PFO defect in a minimally invasive, catheter-based procedure performed by the interventional cardiologist.

Company Contact

CEO
John E. Ahern
CFO
Richard E. Davis
Headquarters
27 Wormwood Street, Boston, MA 02210
Phone
617-737-0930 · Toll-Free 800-666-6484
Fax
617-737-0924
Investor Relations
Richard E. Davis · 617-737-0930 · investorrelations@nmtmedical.com
General Email
info@nmtmedical.com
SEC EDGAR Filings
View filings »